C. Thomas Caskey, M.D., is Professor, Molecular Human Genetics at Baylor College of Medicine. He was Director and Chief Executive Officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), at the University of Texas Health Science Center at Houston. Dr. Caskey was founding Director of Houston-based Cogene Biotech Ventures and Cogene Ventures, venture capital funds supporting early-stage biotechnology and life sciences companies. He has received numerous academic and industry-related honors. He is a member of the National Academy of Sciences, the Institute of Medicine, and the Royal Society of Canada. He has served as President of the American Society of Human Genetics, the Human Genome Organization and The Academy of Medicine, Engineering and Science of Texas (TAMEST). Dr. Caskey previously served as Senior Vice President for Human Genetics and Vaccines Discovery at Merck Research Laboratories from 1994 to 2000 and as President of the Merck Genome Research Institute from 1998 to 2000. His genetic research documented the universality of the genetic code, discovered the mechanism of peptide chain termination, identified the genetic basis of 10 major heritable diseases, opened the understanding of triplet repeat diseases (Fragile X, myotonic dystrophy and others), developed the STR method of DNA-based personal identification (now used worldwide) for forensic studies, and developed a viral vector vaccine for HIV. He received the Distinguished Texas Geneticist Award from the Texas Genetics Society in 1998 and served on Texas Governor Rick Perry's Council on Science and Biotechnology, which makes funding recommendations for the $200 million Texas Emerging Technology Fund. Dr. Caskey earned his medical degree from Duke University School of Medicine and his undergraduate degree from the University of South Carolina. He is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases and Molecular Diagnostics.